Supportedby Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences,Sino-AUS Genesis Stem Cell was founded jointly by Genesis Stem Cell and MonashImmunology and Stem Cell Laboratories. Sino-AUS Genesis Stem Cell is ahigh-tech enterprise focusing on pluripotent stem cell in terms oftechnological development, storage service, and clinical application. GenesisStem Cell actively participates in the major project of national "863project-Clinical translational research and application of stem cell technologyand therapy" and “973 project”, possessing patent of pluripotent stem cellseparation technology in line with Patent Cooperation Treaty (PCT). Sino-AUSGenesis is the only enterprise in China which owns stem cell injection manufacturingand management standards, clinical registration certificate granted by ChinaFood and Drug Administration (CFDA). Sino-AUS Genesis is also the onlyenterprise that passes human safety verification in line with the GCPrequirements. Sino-AUS Genesis has established translational clinic bases inBeijing, Nantong, Kunming (under construction), andMelbourne. It occupies the leading position in the field of Mesenchymal StemCells (MSC) research and industrialization.
